Lab Tools

» biomarkers, flow cytometry and cancer

Most Recent

image: Pinpointing the Culprit

Pinpointing the Culprit

By | June 1, 2017

Identifying immune cell subsets with CyTOF

0 Comments

image: Using Raman Spectroscopy to Identify Cell Types

Using Raman Spectroscopy to Identify Cell Types

By | December 1, 2016

Improvements in instruments and statistical tools allow the capture and analysis of large data sets.

0 Comments

image: Techniques for Assessing Genomic Copy Number Variations

Techniques for Assessing Genomic Copy Number Variations

By | October 1, 2016

As the importance of genomic copy number variations for health and disease becomes clearer, researchers are creating new ways to detect these changes in the genome.

0 Comments

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Free Flow

Free Flow

By | December 1, 2015

A sampling of free software for flow cytometry data analysis

0 Comments

image: Flow Cytometry On-a-Chip

Flow Cytometry On-a-Chip

By | June 1, 2015

Novel microfluidic devices give researchers new ways to count and sort single cells.

0 Comments

image: In Custody

In Custody

By | April 1, 2015

Expert tips for isolating and culturing cancer stem cells

1 Comment

image: Sorting Made Simpler

Sorting Made Simpler

By | December 1, 2014

A guide to affordable, compact fluorescence-activated cell sorters

1 Comment

image: Capturing Cancer Cells on the Move

Capturing Cancer Cells on the Move

By | April 1, 2014

Three approaches for isolating and characterizing rare tumor cells circulating in the bloodstream

2 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Authors Peeved by APA’s Article Takedown Pilot
  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Was a Drop in CRISPR Firms’ Stock Warranted?
AAAS